Geolin, Luzvilla L.

HRN: 28-90-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
CEFTRIAXONE 1G (VIAL)
04/25/2026
05/02/2026
IVT
2g
OD
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: